HURA · TuHURA Biosciences, Inc./NV
$2.05
-0.09 (-3.99%)
At close · Jul 29
Market Cap
$135.64M
Shares
63.68M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$0
FY2025
Net Income
-$31M
-34.8%
FY2025
Diluted EPS
-$0.63
+47.9%
FY2025
Operating Cash Flow
-$27.63M
-87.6%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2013 | FY2014 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | $0 | $0 | — | — | — | — | — | — | — | — | — | — | — | $0 | |
| $21.18M | $20.53M | $13.34M | $9.31M | $15.17M | $11.82M | $3.63M | -$3.66M | -$7.13M | $5M | $3.36M | -$2.56M | $4.99M | $2.34M | — | |
| $7.86M | $7.58M | $4.31M | $5.49M | $7.51M | $9.76M | $4.51M | -$4.74M | -$4.04M | $3.32M | $2.85M | -$2.17M | $5.42M | $3.95M | — | |
| — | — | — | $3.23M | $2000 | $2000 | $9953 | $16.35K | $24.53K | $16.68K | — | — | — | — | — | |
| — | $71.27K | $116.71K | — | — | — | — | — | — | — | — | — | — | — | — | |
| $32.31M | $31.8M | $17.65M | $14.8M | $22.68M | -$38.17M | $9.2M | -$8.4M | -$11.17M | $8.32M | $6.21M | -$4.72M | $10.4M | $6.29M | $57.6K | |
| -$11.52K | — | — | — | — | — | — | — | — | — | — | — | — | — | -$57.6K | |
| — | $625.28K | $4.14M | — | $30K | $30K | — | — | — | — | $2091 | -$2091 | $37.47K | $8020 | — | |
| $1.38M | $1.74M | -$4.03M | $147K | $21K | -$132K | $72.33K | -$350.28K | -$36.35K | -$239.07K | -$2.65M | -$376.89K | -$1.73M | -$2M | — | |
| — | -$30.05M | $21.7M | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | $1600 | $3768 | — | — | — | — | — | — | — | — | — | — | — | — | |
| -$31.87M | -$31M | -$23M | -$15M | -$22.66M | -$38.3M | -$9.13M | $8.05M | $11.14M | $8.08M | -$8.86M | -$4.35M | -$12.13M | -$8.29M | -$57.6K | |
| -$30.93M | -$30.06M | -$22.65M | -$15.02M | -$25.13M | -$41.5M | -$9.13M | $8.13M | $11.31M | $8.87M | — | — | — | — | — | |
| -$10.13M | — | — | — | — | — | — | — | — | — | -$8.86M | $4.35M | -$12.11M | -$8.29M | — | |
| USD/shares | — | -$0.63 | -$1.21 | -$324.45 | -$910.00 | -$2,800.00 | $1,522.50 | $5,530.00 | $945.00 | $1,295.00 | $1,417.50 | $192.50 | — | — | -$17.50 |
| USD/shares | — | -$0.63 | -$1.21 | — | — | — | — | — | — | — | — | $192.50 | — | — | — |
| shares | — | 47.93M | 18.66M | 46.29K | 27.83K | 14.79K | 5968.0257 | 1471.2526 | 11.92K | 6884.0451 | 6256.2749 | 21.75K | 16.95K | 16.95K | 1791.8874 |
| shares | — | 47.93M | 18.66M | — | — | — | — | — | — | — | — | 21.75K | 16.95K | 16.95K | 2253.7143 |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 4.65×
EV/EBIT
—
Peer median 26.45×
P/E (TTM)
—
Peer median 3.39×
Peer medians compare against the 298 similar-size Biotechnology companies (of 522 listed).
Key facts
CIK
1498382
CUSIP
898920103
13F (30d)
17 filings
17 filers
Visit website
Investor relations